Anneliene Jonker, PhD, is the Funding and Strategy Officer of the TechMed Centre, at the University of Twente, in Enschede, The Netherlands. In this position, she is responsible for setting up funding strategies for different researchers in the personalized medicine-, medtech, and rare diseases domain, working with academic and industrial researchers. In addition she assists in the constitution of new collaborations with different stakeholders, to create new research and implementation projects. Anneliene has previously worked at the IRDiRC Scientific Secretariat, as Project and Communication Manager and has been involved with many of the different tasks of the consortium. Anneliene Jonker has had a long interest in rare diseases, and was trained as a biomedical scientist, obtaining her PhD in genetics and metabolism of Ewing’ sarcoma, a rare childhood cancer, at Institut Curie, Paris, France. In addition, she has a master’s degree in the history of medicine, dedicated to rare bone diseases, from the Free University of Amsterdam, Amsterdam, The Netherlands. She is currently a member of the IRDiRC (International Rare Disease Research Consortium) Therapies Scientific Committee.